Who owns CASI PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Casi Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Casi Pharmaceuticals stock

Who bought or sold CASI PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Wellington Shields Capital Management 133k $953k -13% Dec 2023
 View chart
Wellington Shields & Co 44k $317k -40% Dec 2023
 View chart
Geode Capital Management 22k $57k 0% Sep 2023
 View chart
Franklin Resources 20k $144k 0% Dec 2023
 View chart
Renaissance Technologies 18k $46k 18% Sep 2023
 View chart
Citadel Advisors 17k $120k 100% Dec 2023
 View chart
Jane Street 13k $90k -43% Dec 2023
 View chart
Morgan Stanley 1.6k $4.0k 0% Sep 2023
 View chart
UBS Group 1.2k $8.8k 100% Dec 2023
 View chart
Qube Research & Technologies 328.00 $840.008000 100% Sep 2023
 View chart
Tower Research Capital 327.00 $836.989200 60% Sep 2023
 View chart
BlackRock 324.00 $828.986400 -29% Sep 2023
 View chart
West Paces Advisors 100.00 $716.000000 0% Dec 2023
 View chart
Simplex Trading 53.00 $0 100% Dec 2023
 View chart
Jpmorgan Chase & Co 25.00 $182.000000 0% Dec 2023
 View chart
Northwestern Mutual Wealth Management Company 13.00 $33.000500 0% Sep 2023
 View chart
Colonial Trust Co / SC 11.00 $28.000500 0% Sep 2023
 View chart
Kozak & Associates 10.00 $54.000000 0% Dec 2023
 View chart
Wells Fargo & Company 6.00 $43.000200 0% Dec 2023
 View chart
Bank of America Corporation 3.00 $21.000000 0% Dec 2023
 View chart

Who sold out of Casi Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Vanguard Group Sep 2023 32k $83k
Northern Trust Jun 2023 10k $26k
Royal Bank of Canada Sep 2023 18.00 $0